1. Home
  2. CHWY vs WAT Comparison

CHWY vs WAT Comparison

Compare CHWY & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHWY
  • WAT
  • Stock Information
  • Founded
  • CHWY 2010
  • WAT 1958
  • Country
  • CHWY United States
  • WAT United States
  • Employees
  • CHWY N/A
  • WAT N/A
  • Industry
  • CHWY Catalog/Specialty Distribution
  • WAT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CHWY Consumer Discretionary
  • WAT Industrials
  • Exchange
  • CHWY Nasdaq
  • WAT Nasdaq
  • Market Cap
  • CHWY 16.5B
  • WAT 17.4B
  • IPO Year
  • CHWY 2019
  • WAT 1995
  • Fundamental
  • Price
  • CHWY $32.73
  • WAT $345.95
  • Analyst Decision
  • CHWY Strong Buy
  • WAT Buy
  • Analyst Count
  • CHWY 25
  • WAT 15
  • Target Price
  • CHWY $45.17
  • WAT $373.13
  • AVG Volume (30 Days)
  • CHWY 6.1M
  • WAT 641.3K
  • Earning Date
  • CHWY 12-03-2025
  • WAT 11-04-2025
  • Dividend Yield
  • CHWY N/A
  • WAT N/A
  • EPS Growth
  • CHWY N/A
  • WAT 10.77
  • EPS
  • CHWY 0.35
  • WAT 11.09
  • Revenue
  • CHWY $12,345,235,000.00
  • WAT $3,046,056,000.00
  • Revenue This Year
  • CHWY $8.47
  • WAT $7.12
  • Revenue Next Year
  • CHWY $8.12
  • WAT $6.22
  • P/E Ratio
  • CHWY $94.25
  • WAT $31.18
  • Revenue Growth
  • CHWY 9.17
  • WAT 5.89
  • 52 Week Low
  • CHWY $28.36
  • WAT $275.05
  • 52 Week High
  • CHWY $48.62
  • WAT $423.56
  • Technical
  • Relative Strength Index (RSI)
  • CHWY 28.26
  • WAT 59.72
  • Support Level
  • CHWY $33.02
  • WAT $340.09
  • Resistance Level
  • CHWY $34.97
  • WAT $352.76
  • Average True Range (ATR)
  • CHWY 1.06
  • WAT 9.64
  • MACD
  • CHWY -0.38
  • WAT -1.17
  • Stochastic Oscillator
  • CHWY 4.62
  • WAT 54.15

About CHWY Chewy Inc.

Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: